Onconova Therapeutics, Inc. to Present Corporate Overview at Biotech Showcase 2017
Jan 05, 2017 13:31 pm UTC| Business
NEWTOWN, Pa., Jan. 05, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that...
Onconova Therapeutics, Inc. to Present Corporate Overview at Biotech Showcase 2017
Jan 05, 2017 13:31 pm UTC| Business
NEWTOWN, Pa., Jan. 05, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that...
Cellectar Biosciences to Present at the 9th Annual Biotech Showcase
Jan 05, 2017 13:31 pm UTC| Business
MADISON, Wis., Jan. 05, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company, announces today that President and CEO, Jim Caruso will present at the Biotech...
Cellectar Biosciences to Present at the 9th Annual Biotech Showcase
Jan 05, 2017 13:31 pm UTC| Business
MADISON, Wis., Jan. 05, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company, announces today that President and CEO, Jim Caruso will present at the Biotech...
OncoMed Announces Year-End Cash Balance and 2017 Outlook
Jan 05, 2017 13:31 pm UTC| Business
Enters 2017 with $184.6 Million in Cash Potential for Five Program Opt-ins Totaling Over $170M Anti-TIGIT (I/O#2) IND Filed REDWOOD CITY, Calif., Jan. 05, 2017 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a...
OncoMed Announces Year-End Cash Balance and 2017 Outlook
Jan 05, 2017 13:31 pm UTC| Business
Enters 2017 with $184.6 Million in Cash Potential for Five Program Opt-ins Totaling Over $170M Anti-TIGIT (I/O#2) IND Filed REDWOOD CITY, Calif., Jan. 05, 2017 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a...
Amyris Appoints Kathleen Valiasek as Chief Financial Officer
Jan 05, 2017 13:30 pm UTC| Business
Senior Finance and Business Veteran with Fortune 500 Experience Joins Company Following Very Strong Year of Sustainable Growth EMERYVILLE, Calif., Jan. 05, 2017 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience...